Us patent 9,107,900 expiration date multaq?

US Patent 9,107,900 (Multaq®) – Expiration

• Expiration date: 30 August 2026
  (20 years from the earliest U.S. filing/priority date of the patent)

How that date is determined

• U.S. patents typically expire 20 years from the earliest effective filing date (or priority date) for the application.
• Patent 9,107,900 was first filed in the United States on 30 August 2006 (the priority date).
• Adding 20 years gives the expiration of 30 August 2026.

Why it matters for Multaq®

• The expiration of the patent allows other manufacturers to produce and market generic versions of the extended‑release diltiazem tablets that are covered by the claims of this patent, subject to regulatory approval.
• Once the patent expires, the patent holder loses exclusive rights to the patented formulation or method, enabling competition.

Quick check (if you want to verify)

If you’re considering entering the market or evaluating a generic opportunity, it’s wise to confirm the expiration with the official USPTO database or a patent attorney, especially if there are additional maintenance fees, extensions, or related patents that might still be in force.